- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06505122
Dyadic Life Review Intervention for Older Patients With Advanced Cancer) and Their Caregivers (DLR RCT)
March 18, 2026 updated by: Lee Kehoe, University of Rochester
A Pilot Randomized Controlled Trial (RCT) of a Dyadic Life Review Intervention for Older Patients With Advanced Cancer) and Their Caregivers
The purpose of this study is to test the feasibility of a pilot Randomized Controlled Trial (RCT) comparing Dyadic Life Review (DLR) intervention in older adults with advanced cancer and their caregivers to Care-as-Usual (CAU) group, which involves a referral to social work.
Study Overview
Detailed Description
The purpose of this study is to test the feasibility of a pilot Randomized Controlled Trial (RCT) comparing Dyadic Life Review (DLR) intervention in older adults with advanced cancer and their caregivers to Care-as-Usual (CAU) group, which involves a referral to social work.
The study will enroll dyads (pairs) of caregivers and older patients with advanced cancer and dyads of caregivers and patients with advanced cancer.
A previous single-arm study was performed testing the feasibility of the adapted DLR intervention in older adults with advanced cancer and their caregivers.
The single-arm pilot demonstrated DLR was feasible and acceptable by both patients and caregivers.
This innovative pilot study will gather data to test the feasibility of a pilot and examine pre-post intervention changes in caregiver psychological distress.
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lauren Mitchell
- Phone Number: 585-275-1192
- Email: Lauren_Mitchell@URMC.rochester.edu
Study Contact Backup
- Name: Lee Kehoe
- Phone Number: 1-315-567-3924
- Email: lee_kehoe@URMC.rochester.edu
Study Locations
-
-
New York
-
Rochester, New York, United States, 14642
- Recruiting
- University of Rochester
-
Contact:
- Lee Kehoe, PhD
- Phone Number: (585) 276-7686
- Email: Lee_Kehoe@URMC.rochester.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Patient Inclusion Criteria:
- Age ≥ 65
- Patient has a Stage III or IV advanced cancer diagnosis of any type
- Score of 4 or more on National Comprehensive Cancer Network (NCCN) Distress Thermometer (DT)*
- Able to read and understand English
Patient Exclusion Criteria:
• Unable to identify caregiver to participate in study
Caregiver Inclusion Criteria:
- One caregiver must enroll with each patient for either subject to be eligible.
- Caregivers will be selected by the patient when asked if there is a "significant other, spouse, romantic partner, or adult child with whom you discuss or can be helpful in health-related matters;"
- Age 50 or older
- Able to reach and understand English
Caregiver Exclusion Criteria:
• Caregivers unable to provide consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Dyadic Life Review
The Dyadic Life Review Arm (DLR) consists of 8 sessions delivered by a trained licensed clinician.
Each session facilitates a recall of each phase of life.
The patient and caregiver will each be asked structured questions to prompt reminiscence of memories from that phase of life.
Interventionists are able to use clinical judgment to prompt further or ask follow-up questions or reflections.
Additionally, the patient and caregiver will be asked to respond to the other dyad member's memory or reflection.
Each session will have flexibility for clinical judgement.
|
DLR is an intervention that will promote relationship closeness, communication, and psychological distress in both older adults and caregivers.
Other Names:
|
|
No Intervention: Case-As-Usual
The Care-As-Usual (CAU) arm will follow current practices for responding to patient distress.
The CAU for patients involves a supportive follow-up phone call from the social work team to further assess the patient's experience of distress.
In some instances, the social worker will use their clinical judgement to further refer the patient to community resources to support distress.
The number of phone calls and any subsequent community referrals or appointments related to distress that occur will be tracked.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
DLR Intervention Enrollment Rate
Time Frame: 18 weeks
|
Evaluate the feasibility of DLR in older patients and caregivers based on enrollment rate.
|
18 weeks
|
|
DLR Intervention Retention Rate
Time Frame: 18 weeks
|
Evaluate the feasibility of DLR in older patients and caregivers based on retention rate.
|
18 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Unidimensional Relationship Closeness Scale
Time Frame: 18 weeks
|
Quality of relationship with care-receiver: assesses quality of relationship between participant and family member and has demonstrated valid scores across several relationship types, including spouses and other family members.
This is a 12-item scale, rated from 1-7 (1=strongly agree, 7=strongly disagree), with a possible total of 84; a higher score indicates a higher level of closeness.
|
18 weeks
|
|
Communication Satisfaction Scale
Time Frame: 18 weeks
|
The observation of each partner's level of satisfaction with various aspects of their communication.
This is a 12-item scale, rated from 1-5 (1=not at all satisfied, 5=extremely satisfied), with a possible total of 60; a higher score indicates greater satisfaction with communication.
|
18 weeks
|
|
Distress Thermometer
Time Frame: 18 weeks
|
A self-report measure to capture distress and identify a list of sources of that distress.
This is a 10-item scale, rated from 0-10 (0=no distress, 10=severe distress), with a possible total of 10; a higher score indicates greater distress.
|
18 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 23, 2025
Primary Completion (Estimated)
August 31, 2026
Study Completion (Estimated)
October 31, 2026
Study Registration Dates
First Submitted
July 10, 2024
First Submitted That Met QC Criteria
July 10, 2024
First Posted (Actual)
July 17, 2024
Study Record Updates
Last Update Posted (Actual)
March 19, 2026
Last Update Submitted That Met QC Criteria
March 18, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UOCPC24051
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
Second Affiliated Hospital of Soochow UniversityNot yet recruitingCancer | Solid Cancer
-
New Mexico Cancer Research AllianceOhio State University Comprehensive Cancer Center; H. Lee Moffitt Cancer Center...RecruitingCancer | Cancer RiskUnited States
-
Children's Hospital of PhiladelphiaCompletedCancer | Childhood CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
UNICANCERRecruitingAdvanced Breast Cancer | Advanced Gastric Cancer | Advanced Urothelial Cancer | Advanced Non Small Cell Lung Cancer (NSCLC)France
Clinical Trials on Dyadic Life Review
-
University of RochesterNational Cancer Institute (NCI); National Institute on Aging (NIA)CompletedCancer, Advanced | Cognitive Impairment, MildUnited States
-
YANG WEN-CHINot yet recruiting
-
The University of Hong KongRecruitingPsychological Distress | Cognitive Function | Social Support | Meaning of Life | Existential SufferingHong Kong
-
Chinese Academy of SciencesUnknown
-
Virginia Commonwealth UniversityMassey Cancer CenterCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm | Refractory Malignant Neoplasm | Locally Advanced Malignant NeoplasmUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Musculoskeletal Complication | Therapy-Related ToxicityUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedGraft Versus Host DiseaseUnited States, United Kingdom, Austria, Germany
-
Fred Hutchinson Cancer CenterCompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedDepression | Hematopoietic and Lymphoid Cell Neoplasm | Myelodysplastic Syndrome | Cancer SurvivorUnited States